Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
PureTech Health acquires remaining 22% interest in Alivio Therapeutics » 07:04
06/16/21
06/16
07:04
06/16/21
07:04
PRTC

PureTech Health

$55.65 /

+ (+0.00%)

PureTech Health announced…

PureTech Health announced the acquisition of the remaining 22% of shares outstanding in its founded entity, Alivio Therapeutics. Alivio's therapeutic candidates, in development for inflammatory disorders including inflammatory bowel disease, or IBD, will be integrated into the company's wholly owned pipeline. The acquisition aligns with PureTech's strategy to advance a wholly owned pipeline designed to harness key immunological, fibrotic and lymphatic system mechanisms to treat serious diseases with significant unmet needs. The programs and the underlying Alivio technology platform are expected to be funded by PureTech as well as through partnerships and grants. The integration of this program is in line with the budget for PureTech, which extends into the first quarter of 2025, as previously guided. The integration also includes the addition of therapeutic candidate, LYT-503/IMB-150, to the company's pipeline, which is being developed in collaboration with Imbrium Therapeutics as a potential non-opioid treatment for interstitial cystitis or bladder pain syndrome. An IND filing for LYT-503/IMB-150 is expected in 2021. PureTech will also continue to evaluate existing and additional anti-inflammatory programs leveraging the Alivio platform technology. The consideration for the acquisition of the minority interests in Alivio consist of a closing cash payment and potential future cash payments upon successful achievement of certain milestones. The transaction is a small transaction for the purposes of Annex 1 of Listing Rule 11 and smaller than a class 2 transaction for the purposes of Listing Rule 10.

ShowHide Related Items >><<
PRTC PureTech Health
$55.65 /

+ (+0.00%)

PRTC PureTech Health
$55.65 /

+ (+0.00%)

02/10/21 Piper Sandler
PureTech Health price target raised to $76 from $66 at Piper Sandler
01/15/21 SVB Leerink
PureTech Health initiated with an Outperform at SVB Leerink
11/17/20 Piper Sandler
PureTech Health initiated with an Overweight at Piper Sandler
Over a month ago
Conference/Events
PureTech Health management to meet virtually with Oppenheimer » 04:55
05/20/21
05/20
04:55
05/20/21
04:55
PRTC

PureTech Health

$51.50 /

+ (+0.00%)

Virtual Meeting to be…

Virtual Meeting to be held on May 20 hosted by Oppenheimer.

ShowHide Related Items >><<
PRTC PureTech Health
$51.50 /

+ (+0.00%)

PRTC PureTech Health
$51.50 /

+ (+0.00%)

02/10/21 Piper Sandler
PureTech Health price target raised to $76 from $66 at Piper Sandler
01/15/21 SVB Leerink
PureTech Health initiated with an Outperform at SVB Leerink
11/17/20 Piper Sandler
PureTech Health initiated with an Overweight at Piper Sandler
Conference/Events
PureTech Health management to meet virtually with Piper Sandler » 10:25
05/14/21
05/14
10:25
05/14/21
10:25
PRTC

PureTech Health

$51.60 /

-0.5 (-0.96%)

Virtual Meeting to be…

Virtual Meeting to be held on May 14 hosted by Piper Sandler.

ShowHide Related Items >><<
PRTC PureTech Health
$51.60 /

-0.5 (-0.96%)

PRTC PureTech Health
$51.60 /

-0.5 (-0.96%)

02/10/21 Piper Sandler
PureTech Health price target raised to $76 from $66 at Piper Sandler
01/15/21 SVB Leerink
PureTech Health initiated with an Outperform at SVB Leerink
11/17/20 Piper Sandler
PureTech Health initiated with an Overweight at Piper Sandler
Conference/Events
PureTech Health management to meet virtually with Oppenheimer » 10:10
05/13/21
05/13
10:10
05/13/21
10:10
PRTC

PureTech Health

$54.73 /

+ (+0.00%)

Virtual Meeting to be…

Virtual Meeting to be held on May 20 hosted by Oppenheimer.

ShowHide Related Items >><<
PRTC PureTech Health
$54.73 /

+ (+0.00%)

PRTC PureTech Health
$54.73 /

+ (+0.00%)

02/10/21 Piper Sandler
PureTech Health price target raised to $76 from $66 at Piper Sandler
01/15/21 SVB Leerink
PureTech Health initiated with an Outperform at SVB Leerink
11/17/20 Piper Sandler
PureTech Health initiated with an Overweight at Piper Sandler
Hot Stocks
PureTech Health entity enters collaborations to evaluate AKL-T01 » 05:43
04/07/21
04/07
05:43
04/07/21
05:43
PRTC

PureTech Health

$62.00 /

+ (+0.00%)

PureTech Health noted…

PureTech Health noted that its founded entity, Akili Interactive announced collaborations with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to evaluate Akili digital therapeutic AKL-T01 as a treatment for patients with cognitive dysfunction following COVID-19. There are currently no approved treatments for cognitive impairments in COVID-19 survivors. Under each collaboration, Akili will work with research teams at each institution to conduct two separate randomized, controlled clinical studies evaluating AKL-T01's ability to target and improve cognitive functioning in COVID-19 survivors who have exhibited a deficit in cognition. AKL-T01 is the first and only digital therapeutic specifically designed to improve attention function. The organizations aim to begin clinical recruitment for the studies in the next month.

ShowHide Related Items >><<
PRTC PureTech Health
$62.00 /

+ (+0.00%)

PRTC PureTech Health
$62.00 /

+ (+0.00%)

02/10/21 Piper Sandler
PureTech Health price target raised to $76 from $66 at Piper Sandler
01/15/21 SVB Leerink
PureTech Health initiated with an Outperform at SVB Leerink
11/17/20 Piper Sandler
PureTech Health initiated with an Overweight at Piper Sandler
Over a quarter ago
Hot Stocks
PureTech Health COO Stephen Muniz to step down in May » 05:21
03/18/21
03/18
05:21
03/18/21
05:21
PRTC

PureTech Health

$58.00 /

+2.14 (+3.83%)

PureTech Health announced…

PureTech Health announced that Stephen Muniz will retire from his role as COO and corporate secretary and will step down from the board of directors, effective May 17. Bharatt Chowrira, PureTech's president and chief of business and strategy and a member of the board, will assume the responsibilities previously held by Muniz .

ShowHide Related Items >><<
PRTC PureTech Health
$58.00 /

+2.14 (+3.83%)

PRTC PureTech Health
$58.00 /

+2.14 (+3.83%)

02/10/21 Piper Sandler
PureTech Health price target raised to $76 from $66 at Piper Sandler
01/15/21 SVB Leerink
PureTech Health initiated with an Outperform at SVB Leerink
11/17/20 Piper Sandler
PureTech Health initiated with an Overweight at Piper Sandler
Recommendations
PureTech Health price target raised to $76 from $66 at Piper Sandler » 09:39
02/10/21
02/10
09:39
02/10/21
09:39
PRTC

PureTech Health

$57.00 /

+ (+0.00%)

, KRTX

Karuna Therapeutics

$114.79 /

-10.21 (-8.17%)

, VOR

Vor Biopharma

$43.00 /

+0.17 (+0.40%)

Piper Sandler analyst…

Piper Sandler analyst Edward Tenthoff raised the firm's price target on PureTech Health (PRTC) to $76 from $66 and reiterates an Overweight rating on the shares. Puretech sold 1M Karuna Therapeutics (KRTX) shares for $118M and still holds 2.4M shares or about 9% of Karuna, Tenthoff tells investors in a research note. Separately, Vor Biopharma (VOR) completed a successful initial public offering and PureTech retains 3.2M Vor shares, the analyst adds. These two deals account for the target raise.

ShowHide Related Items >><<
VOR Vor Biopharma
$43.00 /

+0.17 (+0.40%)

PRTC PureTech Health
$57.00 /

+ (+0.00%)

KRTX Karuna Therapeutics
$114.79 /

-10.21 (-8.17%)

PRTC PureTech Health
$57.00 /

+ (+0.00%)

01/15/21 SVB Leerink
PureTech Health initiated with an Outperform at SVB Leerink
11/17/20 Piper Sandler
PureTech Health initiated with an Overweight at Piper Sandler
KRTX Karuna Therapeutics
$114.79 /

-10.21 (-8.17%)

02/09/21
Fly Intel: Top five analyst initiations
02/09/21 RBC Capital
Karuna Therapeutics initiated with an Outperform at RBC Capital
11/19/20 Maxim
Karuna Therapeutics initiated with a Buy at Maxim
10/14/20 Citi
Karuna Therapeutics trial news a positive, says Citi
VOR Vor Biopharma
$43.00 /

+0.17 (+0.40%)

KRTX Karuna Therapeutics
$114.79 /

-10.21 (-8.17%)

  • 05
    Feb
VOR Vor Biopharma
$43.00 /

+0.17 (+0.40%)

KRTX Karuna Therapeutics
$114.79 /

-10.21 (-8.17%)

Initiation
PureTech Health initiated with an Outperform at SVB Leerink » 08:34
01/15/21
01/15
08:34
01/15/21
08:34
PRTC

PureTech Health

$54.00 /

-1.9 (-3.40%)

SVB Leerink analyst…

SVB Leerink analyst Thomas J. Smith initiated coverage of PureTech Health with an Outperform rating and $70 price target. Smith says LYT-100, a deuterated form of pirfenidone, has demonstrated potentially improved PK and safety/tolerability relative to the parent molecule, and is currently being evaluated in Phase 2 trials to treat breast cancer-related lymphedema and post-acute COVID-19 respiratory complications, while the company is also planning to advance LYT-100 in progressive-fibrotic interstitial lung diseases including idiopathic pulmonary fibrosis, where the analyst believes LYT-100 could differentiate on better safety/tolerability, potentially enhanced efficacy, and less frequent dosing that could displace pirfenidone as backbone standard of care.

ShowHide Related Items >><<
PRTC PureTech Health
$54.00 /

-1.9 (-3.40%)

PRTC PureTech Health
$54.00 /

-1.9 (-3.40%)

11/17/20 Piper Sandler
PureTech Health initiated with an Overweight at Piper Sandler
Hot Stocks
PureTech Health announces Vor Biopharma receives FDA clearance for VOR33 IND » 07:12
01/14/21
01/14
07:12
01/14/21
07:12
PRTC

PureTech Health

$55.00 /

-2 (-3.51%)

PureTech Health noted…

PureTech Health noted that its founded entity, Vor Biopharma, announced that the FDA has cleared the company's investigational new drug, or IND, application for VOR33, an eHSC therapy candidate being developed for the treatment of acute myeloid leukemia. Vor plans to initiate a Phase 1/2a clinical trial for VOR33 in the first half of this year.

ShowHide Related Items >><<
PRTC PureTech Health
$55.00 /

-2 (-3.51%)

PRTC PureTech Health
$55.00 /

-2 (-3.51%)

11/17/20 Piper Sandler
PureTech Health initiated with an Overweight at Piper Sandler
Hot Stocks
PureTech Health appoints George Farmer as CFO » 05:31
01/05/21
01/05
05:31
01/05/21
05:31
PRTC

PureTech Health

$53.64 /

-0.36 (-0.67%)

PureTech Health announced…

PureTech Health announced that George Farmer has been appointed CFO. Farmer will be responsible for all aspects of the company's finances, including capital markets strategy and execution, strategic and financial planning, and financial reporting. Farmer joins PureTech from BMO Capital Markets where he completed a 15-year career as a senior biotechnology equity analyst providing sector research for institutional investor clients.

ShowHide Related Items >><<
PRTC PureTech Health
$53.64 /

-0.36 (-0.67%)

PRTC PureTech Health
$53.64 /

-0.36 (-0.67%)

11/17/20 Piper Sandler
PureTech Health initiated with an Overweight at Piper Sandler

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.